-
Recent Posts
- Will ProText Mobility, Inc. (OTCQB: TXTM) Find a Way to Monetize Applications for Mobile Communications Market?
- Can Tranzbyte Corporation (PINKSHEETS: ERBB) Overcome Concerns Surrounding Marijuana Business?
- SoundBite Communications (NASDAQ: SDBT) Surges Following Acquisition Agreement
- Is Regenerative Medicine Realistic for YaFarm Technologies (PINKSHEETS: YFRM)?
- Can Raptor Pharmaceutical Corp. (NASDAQ: RPTP) Turn FDA Approval into Big Payday Down the Road?
Categories
OTC Equity Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
Tags
aapl advertising alternative energy amex apple basic materials biopharmaceutical biotechnology cancer capital goods cloud computing copper drilling energy energy stocks exploration facebook fda fda approval gas gold gold mining google healthcare stocks investors ipad iphone mining NASDAQ natural gas nyse oil oil and gas otcbb penny stock penny stocks petroleum pharmaceutical pinksheets Pink Sheets s silver sprint stocks tradingSite
OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.
Registration to our newsletter is FREE, Join today by entering your email below!
Tag Archives: parkinson’s
Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) Takes Off Following Positive Data from Parkinson’s Study
The year just keeps getting better for Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) and for those shareholders that managed to build a big position just over four months ago when shares were trading as low as 1.80. On Thursday ACAD shot … Continue reading
Posted in Articles, NASDAQ
Tagged acad, acadia pharmaceuticals, alzheimer's, fda, investors, parkinson's, pimavanserin, psychosis
Leave a comment
Does Amarantus BioSciences, Inc. (OTCBB: AMBS) Have the Inside Track for New Treatments for Parkinson’s and Alzheimer’s?
Amarantus BioSciences, Inc. (OTCBB: AMBS) is positioning itself to close the week on a high note as the biotechnology company that develops new treatments and diagnostics for Parkinson’s disease and Traumatic Brain Injury centered on their proprietary anti-apoptotis therapeutic protein … Continue reading
Posted in Uncategorized
Tagged alzheimer's, amarantus biosciences, biotechnology, brain injury, investors, manf, parkinson's
Leave a comment
BrainStorm Cell Therapeutics (OTCBB: BCLI) Share Price and Volume Jump on Research Analyst Report Despite Absence of Revenue and Products
Take a company like BrainStorm Cell Therapeutics (OTCBB: BCLI), which has been trading around the 0.25 – 0.30 with minimal volume over the past several months, throw in a “Buy” recommendation from a research analyst that predicts share price to … Continue reading
Posted in Articles, OTC Bulletin Board, Penny Stocks
Tagged als, bcli, brainstrom cell, fda, fda approval, investors, ms, nurown, otcbb, parkinson's, penny stocks, stem cell
Leave a comment
Prana Biotechnology Ltd. (NASDAQ: PRAN) Surging on Alzheimer’s News but will Company be Worth Remembering?
Investors who managed to load up on Prana Biotechnology Ltd. (NASDAQ: PRAN) last week while shares were trading between the 1.43 and 1.55 range couldn’t be happier with the biotechnology company as the price has soared to a high of … Continue reading
Posted in Articles, NASDAQ, Small Cap
Tagged alzheimer's disease, drug development, fda, investors, NASDAQ, parkinson's, pbt2, penny stocks, pran, prana biotechnology
Leave a comment


